OIC 2021
Oncologic Imaging Course 2021
July 1–3, 2021
Lectures
Invited Lecture - Artificial Intelligence
39:19H-P. Schlemmer, Heidelberg/DE
Invited Lecture: Artificial Intelligence
J. Ricke, Munich/DE
Session 1 - Radiology in the time of a pandemic
99:10M. D'Anastasi, Msida/MT
Chest CT features of COVID 19
D. Caruso, Rome/IT
One year of Coronavirus: Challenges and opportunities for radiology
H. Hricak, New York/US
Teleradiology and Online Tumor Boards - The future?
E. Neri, Pisa/IT
Oncologic Imaging Education: Where are the gaps?
M. Ginsberg, New York/US
Q&A
M. D'Anastasi, Msida/MT, E. Neri, Pisa/IT, H-P. Schlemmer, Heidelberg/DE
Session 2 - Principles of oncologic imaging and reporting
99:20H-P. Schlemmer, Heidelberg/DE
How to make your reports user-friendly and what to avoid
M. Ginsberg, New York/US
Common errors in oncologic imaging
D. Regge, Torino/IT
RECIST: Case-based
M. D'Anastasi, Msida/MT
New horizon lecture: Emerging technologies for oncologic imaging: Challenges to clinical translation
M. Ginsberg, New York/US
Q&A
Session 3 - Thoracic oncology
77:12C. Herold, Vienna/AT
Lung cancer screening: Update
H. Prosch, Vienna/AT
I find a nodule - What do I do?
C. Herold, Vienna/AT
Lung infections in oncologic patients: Differential diagnoses
W. Kunz, Munich/DE
Q&A
Session 4 - Hepatobiliary and Pancreatic Oncology
84:18J. Ricke, Munich/DE
Reporting liver lesions - What the surgeon or interventional radiologist must know
D. Tamandl, Vienna/AT
Pancreatic Carcinoma: State of the art imaging
G. Zamboni, Verona/IT
Cystic neoplasms of the pancreas
G. Zamboni, Verona/IT
Q&A
Session 5 - Prostate
100:33D. Regge, Torino/IT
mpMRI: Principles and integration in the clinical pathway
H-P. Schlemmer, Heidelberg/DE
Standardized reporting: PIRADS v2.1 and beyond
D. Bonekamp, Heidelberg/DE
Imaging of the treated prostate
A. Vargas, New York/US
Cases from everyday routine
D. Bonekamp, Heidelberg/DE, H-P. Schlemmer, Heidelberg/DE
Q&A
Session 6 - Special focus: Women's imaging: GYN
81:28T. Helbich, Vienna/AT
Cervical Cancer: Role of MRI in treatment planning
H. Hricak, New York/US
Characterisation of ovarian lesions with MRI - Case-based
A. Vargas, New York/US
Added value of hybrid imaging in gynaecological malignancies
C. Cyran, Munich/DE
Q&A
Session 7 - Special focus: Women's imaging: Breast
160:51T. Helbich, Vienna/AT
Tomosynthesis and Contrast-enhanced Mammography: A new state-of-the-art?
T. Helbich, Vienna/AT
MRI: Abbreviated vs. full-protocol - Which is the way to go?
K.N. Feigin, New York/US
The treated breast
M. Fuchsjäger, Graz/AT
Q&A
Clinical Implementation of DWI of the breast
K. Pinker-Domenig, New York/US
Only B-mode ultrasound or more?
B. Brkljacic, Zagreb/HR
COVID-19: Impact on and considerations for breast imaging
K.N. Feigin, New York/US
Q&A
Session 8 - Gastrointestinal
98:53E. Neri, Pisa/IT
Gastroenteropancreatic neuroendocrine tumours: Imaging and staging
A. Ba-Ssalamah, Vienna/AT
Rectal cancer: The radiological perspective
M.J. Gollub, News York/US
Rectal cancer: A surgical perspective
E. Pappou, New York/US
Clinical cases
M.J. Gollub, News York/US
Q&A
Session 9 - MSK Oncology
65:01M.F. Reiser, Munich/DE
Focal bone lesions and cancer mimics
M.F. Reiser, Munich/DE/US
Bone marrow malignancies: How to assess with imaging
M. Mayerhöfer, New York/US
Soft tissue sarcomas - What the surgeon wants to know
T. Bäuerle, Erlangen/DE
Q&A
Session 10 - Special focus: Neuro + Head and Neck Oncology: It's all about anatomy!
97:35E. Neri, Pisa/IT
Imaging features of sinonasal tumours
S. Stöcklein, Munich/DE
Tumours of the oral cavity and oropharynx
E. Neri, Pisa/IT
Tumours of the larynx
S. Stöcklein, Munich/DE
Added value of PET-CT in staging and response asessment of H&N tumours
C. Cyran, Munich/DE
Q&A